Selective modification of a private I-A allo-stimulating determinant(s) upon association of antigen with an antigen-presenting cell
about
Peptide-mediated modulation of T-cell allorecognition.Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases.Biosynthesis, glycosylation, and partial N-terminal amino acid sequence of the T-cell-activating protein TAP.Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus.Analysis of thymocyte MHC specificity with thymocyte hybridomas.Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. II. Competitive inhibition of I-E-restricted, antigen-specific T cell responsesTAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytesI-A-restricted T cell antigen recognition. Analysis of the roles of A alpha and A beta using DNA-mediated gene transfer.Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodiesPeptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signalingRecombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndromePhotoaffinity labeling demonstrates binding between Ia molecules and nominal antigen on antigen-presenting cells.Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of T lymphocytes.T-cell activation by peptide antigen: effect of peptide sequence and method of antigen presentationAnalysis of antigen presentation by metabolically inactive accessory cells and their isolated membranesInhibition of T cell activation by MHC blockade.A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.Peptide dependency of alloreactive CD4+ T cell responses.Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985.Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
P2860
Q33664749-9774B4DD-D5B9-4FF2-A9A3-561F9DABD3AFQ34589680-B881D865-FB0F-4DE6-931E-C6555886428FQ34624376-D961678F-44D0-492E-BE07-DAAFEF53042CQ35602920-F1AA6B01-5309-4401-9C6E-B65DAA2097C2Q36349204-E2C05F6D-3F33-43AA-BD59-7A0D7F3BE2BFQ36349652-829471B3-68BD-4352-B626-5AACB508CC49Q36351557-CB74890A-E0A0-420F-B1C9-917DD62FA73EQ36351665-CA575916-98B6-4DE0-9807-63BA875DA49DQ36352195-FE2F2CDB-C912-49C8-9760-9627CF7AD0AEQ36361605-B032CF0E-38C6-4315-8164-9ED5168E385EQ37006573-C9862023-0ED1-4352-982C-E727EA32AAF8Q37392832-79EC023D-5CAD-448A-BF27-B10C0084BBC0Q37399754-70CD9532-FB4F-4B21-88E7-7A791865CE8AQ37546746-0954141B-9D1A-4019-844E-294DF9404F36Q37551056-B958D419-D214-4974-9775-998E0A9928B0Q37804401-052A4B2C-7A93-4C4F-8DB3-A1161F530C9FQ39623507-A4882FDC-719E-4F9F-8BAD-C2DB528FEF79Q40957944-CC19DF45-D8CC-48A8-8F5C-AC9E31BDE875Q41852179-BAD0DB3A-83B5-49FA-BE19-99FAC114962AQ41881939-0F5912C7-98E4-4400-AFEF-B5C7B74C0325Q41940214-068F6355-31B6-45DC-A5BE-C19C1C921D5C
P2860
Selective modification of a private I-A allo-stimulating determinant(s) upon association of antigen with an antigen-presenting cell
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Selective modification of a pr ...... ith an antigen-presenting cell
@ast
Selective modification of a pr ...... ith an antigen-presenting cell
@en
type
label
Selective modification of a pr ...... ith an antigen-presenting cell
@ast
Selective modification of a pr ...... ith an antigen-presenting cell
@en
prefLabel
Selective modification of a pr ...... ith an antigen-presenting cell
@ast
Selective modification of a pr ...... ith an antigen-presenting cell
@en
P2860
P356
P1476
Selective modification of a pr ...... ith an antigen-presenting cell
@en
P2093
P2860
P304
P356
10.1084/JEM.159.4.1238
P407
P577
1984-04-01T00:00:00Z